First-line durvalumab with arterial chemotherapy in major portal invaded hepatocellular carcinoma: The phase 2 DurHope study with biomolecular analyses. Comparative diagnostic accuracy and tumor ...
Morning Overview on MSN
Study: Shutting down an aging enzyme helped knee cartilage grow back
Scientists have long assumed that once the smooth cartilage in a damaged knee wears away, the body has little chance of ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration ...
Research has shown that angiotensin converting enzyme (ACE) inhibitors help manage diabetic nephropathy-related issues. They can also slow the progression of diabetic nephropathy in some people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback